Page last updated: 2024-08-24

triptonide and Angiogenesis, Pathologic

triptonide has been researched along with Angiogenesis, Pathologic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cao, Z; Du, L; Han, H; Zhang, B; Zhou, Q	1

Other Studies

1 other study(ies) available for triptonide and Angiogenesis, Pathologic

Article	Year
Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes. European journal of pharmacology, 2018, Jan-05, Volume: 818 Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Chemokine CXCL2; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Pancreatic Neoplasms; Triterpenes	2018

Article

Year

Triptonide potently suppresses pancreatic cancer cell-mediated vasculogenic mimicry by inhibiting expression of VE-cadherin and chemokine ligand 2 genes.

European journal of pharmacology, 2018, Jan-05, Volume: 818

Topics: Antigens, CD; Antineoplastic Agents; Cadherins; Cell Line, Tumor; Chemokine CXCL2; Drug Discovery; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Invasiveness; Neoplasm Metastasis; Neovascularization, Pathologic; Pancreatic Neoplasms; Triterpenes

2018